Research advances in metabolomics in nonalcoholic fatty liver disease
DOI:10.3969/j.issn.1001-5256.2021.04.047
- VernacularTitle:非酒精性脂肪性肝病代谢组学研究进展
- Author:
Yuting LUAN
1
;
Zhongming HUANG
;
Wenjuan SHEN
;
Minghao HA
;
Zhibing XU
Author Information
1. Department of Infectious Diseases, The Seventh People’s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200137, China
- Publication Type:Research Article
- Keywords:
Non-alcoholic Fatty Liver Disease;
Metabolomics;
Diagnosis
- From:
Journal of Clinical Hepatology
2021;37(4):943-946
- CountryChina
- Language:Chinese
-
Abstract:
The incidence rate of nonalcoholic fatty liver disease (NAFLD) is gradually increasing, and NAFLD has become the most important chronic liver disease in China. At present, the pathogenesis of NAFLD has not been fully elucidated and there are still no effective drugs. From the perspectives of pathogenesis, noninvasive diagnosis, and drug action and efficacy, this article introduces the research advances in metabolomics regarding endogenous small molecule metabolites in NAFLD, so as to provide new ideas and methods for further exploration of NAFLD.
